{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:27Z","timestamp":1787021067975,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST109-2635-B-650-001"],"award-info":[{"award-number":["MOST109-2635-B-650-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"E-Da Cancer Hospital","award":["ECPJ109009"],"award-info":[{"award-number":["ECPJ109009"]}]},{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"crossref","award":["EDAHT110035"],"award-info":[{"award-number":["EDAHT110035"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vitiligo is a skin disorder characterized by the loss of melanocytes (MCs), leading to depigmentation. While the exact mechanisms are unclear, the transcription factor Ets-1, known for its role in regulating matrix metalloproteinase expression and MC migration, is suspected to play a part. Ets-1 gene-deficient mice exhibit a vitiligo-like phenotype with spontaneous skin depigmentation, suggesting a direct link between Ets-1 deficiency and MC dysfunction. This study aimed to characterize the molecular and histological features of Ets-1 gene knockout (KO) mice to understand the underlying mechanisms of this depigmentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Transcriptomic analysis of depigmented and normal skin from Ets-1 KO and wild-type mice revealed significant differentially expressed genes (DEGs). KEGG pathway enrichment analysis demonstrated alterations in metabolic and signal transduction pathways, notably the downregulation of melanogenesis-related genes. RT-qPCR and immunohistochemistry confirmed reduced tyrosinase expression at both transcript and protein levels in the depigmented skin of KO mice. Protein-protein interaction network analysis of the DEGs highlighted a central network involving keratin proteins and discrete interactions regulating melanogenesis, stress response, and cellular signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings demonstrate that Ets-1 deficiency in mice leads to significant molecular and histological changes consistent with MC dysfunction and depigmentation. The observed downregulation of melanogenesis-related genes and alterations in key signaling pathways provide valuable insights into the molecular basis of Ets-1\u2019s role in MC maintenance and suggest potential therapeutic targets for skin pigmentation disorders, including vitiligo.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42826-025-00260-8","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T03:14:39Z","timestamp":1764299679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterization of Ets-1 deficiency-induced depigmentation in a mouse model: insights into vitiligo pathogenesis"],"prefix":"10.1186","volume":"41","author":[{"given":"Wen-Yu","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Shyuan","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Chiu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-9384","authenticated-orcid":false,"given":"Ying-Hsien","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"260_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.dsi.2014.09.008","volume":"32","author":"KI Essien","year":"2014","unstructured":"Essien KI, Harris JE. Animal models of vitiligo: matching the model to the question. Dermatol Sinica. 2014;32:240\u201347.","journal-title":"Dermatol Sinica"},{"key":"260_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2133.1977.tb15180.x","volume":"97","author":"M Koga","year":"1977","unstructured":"Koga M. Vitiligo: a new classification and therapy. Br J Dermatol. 1977;97:255\u201361.","journal-title":"Br J Dermatol"},{"key":"260_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2133.1988.tb01778.x","volume":"118","author":"M Koga","year":"1988","unstructured":"Koga M, Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol. 1988;118:223\u20138.","journal-title":"Br J Dermatol"},{"key":"260_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1365-4362.1980.tb00316.x","volume":"19","author":"AM el-Mofty","year":"1980","unstructured":"el-Mofty AM, el-Mofty M. Vitiligo. A symptom complex. Int J Dermatol. 1980;19:237\u201344.","journal-title":"Int J Dermatol"},{"key":"260_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/35099076","volume":"2","author":"AD Sharrocks","year":"2001","unstructured":"Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol. 2001;2:827\u201337.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"260_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1126\/science.1111915","volume":"309","author":"MA Pufall","year":"2005","unstructured":"Pufall MA, Lee GM, Nelson ML, Kang HS, Velyvis A, Kay LE, et al. Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science. 2005;309:142\u20135.","journal-title":"Science"},{"key":"260_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/377635a0","volume":"377","author":"JC Bories","year":"1995","unstructured":"Bories JC, Willerford DM, Grevin D, Davidson L, Camus A, Martin P, et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature. 1995;377:635\u20138.","journal-title":"Nature"},{"key":"260_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.autrev.2011.01.007","volume":"10","author":"RX Leng","year":"2011","unstructured":"Leng RX, Pan HF, Chen GM, Feng CC, Fan YG, Ye DQ, et al. The dual nature of Ets-1: focus to the pathogenesis of systemic lupus erythematosus. Autoimmun Rev. 2011;10:439\u201343.","journal-title":"Autoimmun Rev"},{"key":"260_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/path.844","volume":"194","author":"P Behrens","year":"2001","unstructured":"Behrens P, Rothe M, Wellmann A, Krischler J, Wernert N. The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol. 2001;194:43\u201350.","journal-title":"J Pathol"},{"key":"260_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-3-031-62731-6_16","volume":"1459","author":"RA Luchtel","year":"2024","unstructured":"Luchtel RA. ETS1 function in leukemia and lymphoma. Adv Exp Med Biol. 2024;1459:359\u201378.","journal-title":"Adv Exp Med Biol"},{"key":"260_CR11","doi-asserted-by":"publisher","first-page":"14100","DOI":"10.1074\/jbc.M601820200","volume":"281","author":"KK Nelson","year":"2006","unstructured":"Nelson KK, Subbaram S, Connor KM, Dasgupta J, Ha XF, Meng TC, et al. Redox-dependent matrix metalloproteinase-1 expression is regulated by JNK through Ets and AP-1 promoter motifs. J Biol Chem. 2006;281:14100\u201310.","journal-title":"J Biol Chem"},{"key":"260_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00018-003-3337-8","volume":"61","author":"T Rothhammer","year":"2004","unstructured":"Rothhammer T, Hahne JC, Florin A, Poser I, Soncin F, Wernert N, et al. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci. 2004;61:118\u201328.","journal-title":"Cell Mol Life Sci"},{"key":"260_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2133.2011.10324.x","volume":"165","author":"R Kumar","year":"2011","unstructured":"Kumar R, Parsad D, Kanwar AJ, Kaul D. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo. Br J Dermatol. 2011;165:285\u201391.","journal-title":"Br J Dermatol"},{"key":"260_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/exd.14107","volume":"29","author":"N Srivastava","year":"2020","unstructured":"Srivastava N, Bishnoi A, Mehta S, Rani S, Kumar R, Bhardwaj S, et al. Aberrant ETS-1 signalling impedes the expression of cell adhesion molecules and matrix metalloproteinases in non-segmental vitiligo. Exp Dermatol. 2020;29:539\u201347.","journal-title":"Exp Dermatol"},{"key":"260_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/pcmr.12284","volume":"27","author":"JM Eby","year":"2014","unstructured":"Eby JM, Kang HK, Klarquist J, Chatterjee S, Mosenson JA, Nishimura MI, et al. Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res. 2014;27:1075\u201385.","journal-title":"Pigment Cell Melanoma Res"},{"key":"260_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","volume":"36","author":"DA Bassiouny","year":"2011","unstructured":"Bassiouny DA, Shaker O. Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol. 2011;36:292\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"260_CR17","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1084\/jem.20070994","volume":"204","author":"J Moisan","year":"2007","unstructured":"Moisan J, Grenningloh R, Bettelli E, Oukka M, Ho IC. Ets-1 is a negative regulator of Th17 differentiation. J Exp Med. 2007;204:2825\u201335.","journal-title":"J Exp Med"},{"key":"260_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1084\/jem.20041330","volume":"201","author":"R Grenningloh","year":"2005","unstructured":"Grenningloh R, Kang BY, Ho IC. Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. J Exp Med. 2005;201:615\u201326.","journal-title":"J Exp Med"},{"key":"260_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jhep.2009.10.002","volume":"52","author":"YH Kao","year":"2010","unstructured":"Kao YH, Chen CL, Jawan B, Chung YH, Sun CK, Kuo SM, et al. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis. J Hepatol. 2010;52:96\u2013105.","journal-title":"J Hepatol"},{"key":"260_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ydbio.2015.04.012","volume":"407","author":"A Saldana-Caboverde","year":"2015","unstructured":"Saldana-Caboverde A, Perera EM, Watkins-Chow DE, Hansen NF, Vemulapalli M, Mullikin JC, et al. The transcription factors Ets1 and Sox10 interact during murine melanocyte development. Dev Biol. 2015;407:300\u201312.","journal-title":"Dev Biol"},{"key":"260_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1567-133X(03)00065-6","volume":"3","author":"SA Tahtakran","year":"2003","unstructured":"Tahtakran SA, Selleck MA. Ets-1 expression is associated with cranial neural crest migration and vasculogenesis in the chick embryo. Gene Expr Patterns. 2003;3:455\u20138.","journal-title":"Gene Expr Patterns"},{"key":"260_CR22","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1242\/dev.047696","volume":"137","author":"Z Gao","year":"2010","unstructured":"Gao Z, Kim GH, Mackinnon AC, Flagg AE, Bassett B, Earley JU, et al. Ets1 is required for proper migration and differentiation of the cardiac neural crest. Development. 2010;137:1543\u201351.","journal-title":"Development"},{"key":"260_CR23","doi-asserted-by":"publisher","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"H Nagase","year":"1999","unstructured":"Nagase H, Woessner JF. Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491\u20134.","journal-title":"J Biol Chem"},{"key":"260_CR24","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1096\/fj.05-4401fje","volume":"19","author":"LA Wilson","year":"2005","unstructured":"Wilson LA, Gemin A, Espiritu R, Singh G. ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element. FASEB J. 2005;19:2085\u20137.","journal-title":"FASEB J"},{"key":"260_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1476-4598-12-138","volume":"12","author":"ML Verschoor","year":"2013","unstructured":"Verschoor ML, Singh G. Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer. Mol Cancer. 2013;12:138.","journal-title":"Mol Cancer"},{"key":"260_CR26","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2174\/1574888X19666230918102826","volume":"19","author":"YH Kao","year":"2024","unstructured":"Kao YH, Chang CY, Lin YC, Chen PH, Lee PH, Chang HR, et al. Mesenchymal stem cell-derived exosomes mitigate acute murine liver injury via Ets-1 and Heme oxygenase-1 up-regulation. Curr Stem Cell Res Ther. 2024;19:906\u201318.","journal-title":"Curr Stem Cell Res Ther"},{"key":"260_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/bjd.15651","volume":"178","author":"XH Yuan","year":"2018","unstructured":"Yuan XH, Jin ZH. Paracrine regulation of melanogenesis. Br J Dermatol. 2018;178:632\u201339.","journal-title":"Br J Dermatol"},{"key":"260_CR28","doi-asserted-by":"publisher","first-page":"1526368","DOI":"10.3389\/fimmu.2025.1526368","volume":"16","author":"S Wang","year":"2025","unstructured":"Wang S, Wan L, Zhang X, Fang H, Zhang M, Li F, et al. ETS-1 in tumor immunology: implications for novel anti-cancer strategies. Front Immunol. 2025;16:1526368.","journal-title":"Front Immunol"},{"key":"260_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cyto.2016.12.014","volume":"91","author":"S Bhardwaj","year":"2017","unstructured":"Bhardwaj S, Rani S, Srivastava N, Kumar R, Parsad D. Increased systemic and epidermal levels of IL-17A and IL-1beta promotes progression of non-segmental vitiligo. Cytokine. 2017;91:153\u201361.","journal-title":"Cytokine"},{"key":"260_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1684\/ejd.2013.2023","volume":"23","author":"MA Elela","year":"2013","unstructured":"Elela MA, Hegazy RA, Fawzy MM, Rashed LA, Rasheed H. Interleukin 17, Interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients. Eur J Dermatol. 2013;23:350\u20135.","journal-title":"Eur J Dermatol"},{"key":"260_CR31","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/jid.2013.540","volume":"134","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Eby JM, Al-Khami AA, Soloshchenko M, Kang HK, Kaur N, et al. A quantitative increase in regulatory T cells controls development of vitiligo. J Invest Dermatol. 2014;134:1285\u201394.","journal-title":"J Invest Dermatol"},{"key":"260_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.autrev.2017.07.005","volume":"16","author":"R Speeckaert","year":"2017","unstructured":"Speeckaert R, Speeckaert M, De Schepper S, van Geel N. Biomarkers of disease activity in vitiligo: A systematic review. Autoimmun Rev. 2017;16:937\u201345.","journal-title":"Autoimmun Rev"},{"key":"260_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","volume":"15","author":"RK Singh","year":"2016","unstructured":"Singh RK, Lee KM, Vujkovic-Cvijin I, Ucmak D, Farahnik B, Abrouk M, et al. The role of IL-17 in vitiligo: A review. Autoimmun Rev. 2016;15:397\u2013404.","journal-title":"Autoimmun Rev"},{"key":"260_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00403-016-1690-3","volume":"308","author":"Y Zhen","year":"2016","unstructured":"Zhen Y, Yao L, Zhong S, Song Y, Cui Y, Li S. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo. Arch Dermatol Res. 2016;308:703\u201310.","journal-title":"Arch Dermatol Res"},{"key":"260_CR35","doi-asserted-by":"publisher","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","volume":"6","author":"CQ Wang","year":"2011","unstructured":"Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, Moussai D, Gulati N, Sullivan-Whalen M, et al. Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS ONE. 2011;6:e18907.","journal-title":"PLoS ONE"},{"key":"260_CR36","doi-asserted-by":"crossref","unstructured":"Zhou J, An X, Dong J, Wang Y, Zhong H, Duan L, et al. IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo. FASEB J. 2018:4899\u2013916.","DOI":"10.1096\/fj.201701242RR"},{"key":"260_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Bettelli","year":"2007","unstructured":"Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8:345\u201350.","journal-title":"Nat Immunol"},{"key":"260_CR38","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3389\/fimmu.2020.00800","volume":"11","author":"AM Bujor","year":"2020","unstructured":"Bujor AM, El Adili F, Parvez A, Marden G, Trojanowska M. Fli1 downregulation in scleroderma myeloid cells has profibrotic and Proinflammatory effects. Front Immunol. 2020;11:800.","journal-title":"Front Immunol"},{"key":"260_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/cells12020217","volume":"12","author":"R Jin","year":"2023","unstructured":"Jin R, Zhou M, Lin F, Xu W, Xu A. Pathogenic Th2 cytokine profile skewing by IFN-\u03b3-Responding vitiligo fibroblasts via CCL2\/CCL8. Cells. 2023;12:217.","journal-title":"Cells"},{"key":"260_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ejcb.2007.02.004","volume":"86","author":"L Planko","year":"2007","unstructured":"Planko L, Bohse K, Hohfeld J, Betz RC, Hanneken S, Eigelshoven S, et al. Identification of a keratin-associated protein with a putative role in vesicle transport. Eur J Cell Biol. 2007;86:827\u201339.","journal-title":"Eur J Cell Biol"},{"key":"260_CR41","doi-asserted-by":"publisher","first-page":"27557","DOI":"10.1074\/jbc.R700026200","volume":"282","author":"Y Yamaguchi","year":"2007","unstructured":"Yamaguchi Y, Brenner M, Hearing VJ. The regulation of skin pigmentation. J Biol Chem. 2007;282:27557\u201361.","journal-title":"J Biol Chem"},{"key":"260_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/wrr.12798","volume":"28","author":"A Gupta","year":"2020","unstructured":"Gupta A, Chauhan A, Priya A, Mantri B, Wadhokar M, Dalave K, et al. Lesional skin in vitiligo exhibits delayed in vivo reepithelialization compared to the nonlesional skin. Wound Repair Regen. 2020;28:307\u201314.","journal-title":"Wound Repair Regen"},{"key":"260_CR43","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jocd.12223","volume":"15","author":"FY Saleh","year":"2016","unstructured":"Saleh FY, Awad SS, Nasif GA, Halim C. Epithelial expression of cytokeratins 15 and 19 in vitiligo. J Cosmet Dermatol. 2016;15:312\u201317.","journal-title":"J Cosmet Dermatol"},{"key":"260_CR44","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1111\/jdv.19022","volume":"37","author":"X Lin","year":"2023","unstructured":"Lin X, Meng X, Lin J. The possible role of Wnt\/beta-catenin signalling in vitiligo treatment. J Eur Acad Dermatol Venereol. 2023;37:2208\u201321.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"260_CR45","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/med.21426","volume":"37","author":"SA Birlea","year":"2017","unstructured":"Birlea SA, Costin GE, Roop DR, Norris DA. Trends in regenerative medicine: repigmentation in vitiligo through melanocyte stem cell mobilization. Med Res Rev. 2017;37:907\u201335.","journal-title":"Med Res Rev"}],"container-title":["Laboratory Animal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-025-00260-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42826-025-00260-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-025-00260-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:02:12Z","timestamp":1781618532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42826-025-00260-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1186\/s42826-025-00260-8","relation":{},"ISSN":["2233-7660"],"issn-type":[{"value":"2233-7660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of laboratory animals was approved by the Institutional Animal Care and Use Committee (IACUC) of E-Da Hospital (Approval nos. IACUC-EDCH-107002 and 108004).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}